Philips Respironics has issued a voluntary … [Read more...]
Philips Respironics Issues Additional Usage Instructions Regarding Trilogy Evo Vents, In-Line Nebulizers
Inogen Announces Q2 Financial Results, Anticipates Overall Growth in 2024
Higher demand and new customers drive growth, the manufacturer reported.
Inogen Inc. (Nasdaq: INGN) is expecting … [Read more...]
Briefly: Inogen to Announce Q2 Earnings; FDA Continues Monitoring Philips Respironics OLA+ Reports
Featuring Inogen, the U.S. Food & Drug Administration, and Philips Respironics.
Inogen to Report Q2 Earnings on Aug. 6 Inogen … [Read more...]
Philips Reaches $1.1 Billion US Settlement
The agreement resolves complaints related to the company’s sleep and respiratory products.
Medical device company Philips has reached an … [Read more...]
Q1 Most-Read: The Industry’s Future Takes Center Stage
The most popular HME Business stories from January through March had a common theme.
The three most-read HME Business stories of Q1 … [Read more...]
Philips Agrees to FDA Consent Decree on Sleep, Respiratory Care Devices
The announcement was part of Philips’ report on sales results.
Philips has agreed to the terms of a consent … [Read more...]
Philips Respironics Announces Major US Portfolio Reductions
Philips will continue to support the products through their end-of-service lifespans.
Philips Respironics has announced major changes to … [Read more...]